NEW YORK and TORONTO, Jan. 30, 2020 — NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29) NexTech AR Solutions, the industry leader in augmented reality, is pleased to announce a major enhancement by expanding […]
AR and Interactive Video combine to create world’s most compelling training platform NEW YORK and TORONTO, Jan. 28, 2020– NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29) NexTech AR Solutions, the industry leader in […]
CytoDyn and IncellDX in discussions with potential partners about the use of leronlimab to treat 2019 Novel Coronavirus (2019-nCoV) VANCOUVER, Washington, Jan. 28, 2020 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology […]
VANCOUVER, Washington, Jan 27, 2020 — The poster and oral presentation will highlight the role of the CCR5 antibody in preventing macaques from intrarectal Simian-Human Immunodeficiency Virus (SHIV) Based on these strong results, CytoDyn has […]
Company enters the multi-billion dollar VR industry NEW YORK and TORONTO, Jan. 22, 2020 — NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29) NexTech AR Solutions, the industry leader in augmented reality, is pleased […]
VANCOUVER, Washington, Jan 22, 2020 — First patient with metastatic triple-negative breast cancer (mTNBC) continues to show no detectable circulating tumor cells (CTC) or putative metastatic tumor cells after 15 weeks of treatment with leronlimab […]
NEW YORK and TORONTO, Jan 17, 2020 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality (AR) for eCommerce and AR learning applications is pleased to announce that NexTech CEO Evan Gappelberg […]
VANCOUVER, Washington, Jan. 13, 2020 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the […]
VANCOUVER, Washington, Jan. 09, 2020 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that it […]
Quarterly Performance Boosted by NexTech’s AR Ecomm division NEW YORK and TORONTO, Jan 07, 2020 – NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29), the industry leader in augmented reality, is pleased to announce […]
Nightfood sleep-friendly ice cream in hotel freezers can deliver better-for-you snacking benefits to road-weary travelers Tarrytown, NY – January 06, 2020 – Nightfood, Inc. (OTCQB: NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar […]
Weby Corp to use NexTech AR’s augmented reality eCommerce technology to drive greater sales through improved online customer experience. NEW YORK and TORONTO, Dec 31, 2019 – NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader […]
Objective clinical responses in these two patients treated with leronlimab (PRO 140) lead to plans for imminent filing of a Breakthrough Therapy Designation Application while trial enrollment efforts continue at much higher pace VANCOUVER, Washington, […]
NEW YORK and TORONTO, Dec 20, 2019 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for eCommerce, learning applications, and branded entertainment experiences is pleased to announce that NexTech’s 3D augmented […]
VANCOUVER, Washington and NEW YORK, Dec 17, 2019 – In exchange for the exclusive right to market and distribute leronlimab in the U.S. for HIV-related indications, Vyera will pay upfront and regulatory and sales-based milestone […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
